Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease

Neurobiology of Aging

Volumn 27, Issue 9, 2006, Pages 1212-1215

  Chapuis, Julien ^a   Tian, Jinzhou ^b,d   Shi, Jing ^b,d   Bensemain, Faiza ^a   Cottel, Dominique ^a   Lendon, Corinne ^c   Amouyel, Philippe ^a   Mann, David ^b   Lambert, Jean Charles ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Queen Elizabeth Psychiatry Hospital   (United Kingdom)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Alzheimer; Arteriosclerosis; Association study; Brain; Cerebral angiopathy amyloid; Polymorphism; Promoter; VEGF; White matter lesion

Indexed keywords

VASCULOTROPIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN REGION; CASE CONTROL STUDY; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FRONTAL CORTEX; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN TISSUE; MALE; NEUROMODULATION; OCCIPITAL CORTEX; PARIETAL LOBE; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; TEMPORAL CORTEX; VASCULAR AMYLOIDOSIS; WHITE MATTER;

AGED; ALZHEIMER DISEASE; BRAIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746013839     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.07.013     Document Type: Article

References (28)

1. Araria-Goumidi L., Lambert J.C., Cottel D., Amouyel P., and Chartier-Harlin M.C. No association of the HLA-A2 allele with Alzheimer's disease. Neurosci Lett 335 (2002) 75-78
2. Blacker D., Bertram L., Saunders A.J., et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12 (2003) 23-32
3. Casserly I., and Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363 (2004) 1139-1146
4. Collins J.S., Perry R.T., Watson Jr. B., et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer disease genetics initiative. Am J Med Genet 96 (2000) 823-830
5. Deane R., Wu Z., Sagare A., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 (2004) 333-344
6. Del Bo R., Scarlato M., Ghezzi S., et al. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 57 (2005) 373-380
7. de la Torre J.C. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26 (2004) 517-524
8. Farkas E., and Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64 (2001) 575-611
9. Farrer L.A., Cupples L.A., Haines J.L., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278 (1997) 1349-1356
10. Greenberg S.M., Gurol M.E., Rosand J., and Smith E.E. Amyloid angiopathy-related vascular cognitive impairment. Stroke 35 (2004) 2616-2619
11. Gorelick P.B. Risk factors for vascular dementia and Alzheimer disease. Stroke 35 (2004) 2620-2622
12. Harris J.M., Cumming A.M., Craddock N., St Clair D., and Lendon C.L. Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. Neurosci Lett 294 (2000) 37-40
13. Infante J., Llorca J., Berciano J., and Combarros O. No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease. Neurosci Lett 328 (2002) 71-73
14. Kalaria R.N., Cohen D.L., Premkumar D.R., Nag S., LaManna J.C., and Lust W.D. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62 (1998) 101-105
15. Lambert J.C., Mann D., Harris J., Araria-Goumidi L., Chartier-Harlin M.C., Cottel D., et al. Association study of Notch 4 polymorphisms with Alzheimer's disease. J Neurol Neurosurg Psychiatry 75 (2004) 377-381
16. Lambrechts D., Storkebaum E., Morimoto M., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34 (2003) 383-394
17. Myers A., Wavrant De-Vrieze F., Holmans P., et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114 (2002) 235-244
18. Roher A.E., Esh C., Rahman A., Kokjohn T.A., and Beach T.G. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 35 (2004) 2623-2627
19. Shibata M., Yamada S., Kumar S.R., et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106 (2000) 1489-1499
20. Storkebaum E., and Carmeliet P. VEGF: a critical player in neurodegeneration. J Clin Invest 113 1 (2004) 14-18
21. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111 (2003) 1843-1851
22. Tian J., Shi J., Bailey K., and Mann D.M. Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 30 (2004) 46-56
23. Tiret L., de Knijff P., Menzel H.J., Ehnholm C., Nicaud V., and Havekes L.M. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb 14 (1994) 1617-1624
24. Vagnucci Jr. A.H., and Li W.W. Alzheimer's disease and angiogenesis. Lancet 361 (2003) 605-608
25. Vinters H.V., and Farag E.S. Amyloidosis of cerebral arteries. Adv Neurol 92 (2003) 105-112
26. Yang S.P., Bae D.G., Kang H.J., Gwag B.J., Gho Y.S., and Chae C.B. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 25 (2004) 283-290
27. Zareparsi S., James D.M., Kaye J.A., Bird T.D., Schellenberg G.D., and Payami H. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology 58 (2002) 973-975
28. Zlokovic B.V. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28 (2005) 202-208